But the company is not wavering in its plans to dramatically hike the price of its COVID ... updated vaccines—to be in the range of $110 to $130," Garay said. In March, Moderna CEO Stéphane ...
Moderna maintained its full-year guidance of a minimum of $5 billion in revenue from its Covid vaccine, which will come from signed government contracts for the shot. CEO Stéphane Bancel said ...
Moderna Inc. brought in more ... to purchase agreement cancellations. In March, CEO Stephane Bancel predicted a 90% drop in demand for Covid vaccines, even as the FDA continues to authorize ...
A vial of the Moderna coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8 ...
This has been worrying investors, weighing on the stock price. But what if I told you the coronavirus vaccine may be only the start of the Moderna story? This innovative biotech has branched out ...
Moderna has pledged never to enforce its coronavirus vaccine patents ... initiatives aimed at increasing vaccine manufacturing capacity in low- and middle-income countries. “It’s a very big ...
That simple, original series of vaccines we got—two doses spaced three weeks apart of either Moderna or Pfizer monovalent COVID vaccines—no longer exist. The monovalent (that’s what they ...
On this week’s episode of Fortune‘s Leadership Next podcast, co-hosts Alan Murray and Michal Lev-Ram talk with Moderna CEO Stephane ... upcoming price increase of the COVID-19 vaccine; and ...
Early in the pandemic, scientists began testing an old TB vaccine against the coronavirus ... restricted in 2021 because of safety concerns. Moderna has paid $400 million to the government ...
Time to put in your nominations for the 25th Annual 40 Under 40. Related: Moderna CEO defends Covid vaccine price hike in Senate grilling Moderna's headcount has grown 370% since the start of the ...
The U.S. Food and Drug Administration has amended emergency use authorizations to recommend bivalent Moderna and Pfizer-BioNTech COVID-19 vaccines be used for all doses administered to residents ...
This has been worrying investors, weighing on the stock price. But what if I told you the coronavirus vaccine may be only the start of the Moderna story? This innovative biotech has branched out ...
